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S U M M A R Y
Strongyloidiasis is one of the most common geohelminth infections in tropical and subtropical areas.
Accurate diagnosis remains challenging, leading to an overall underestimation of strongyloidiasis
prevalence. The possibility of ongoing autochthonous transmission in some temperate areas and
especially in southern Europe is still debated, and data supporting this hypothesis are scarce. The case of
a young French woman, who had travelled frequently to Spain and had acquired Strongyloides stercoralis
infection as revealed by gastrointestinal symptoms and hypereosinophilia, is reported here. Physicians
should keep in mind the risk of being infected in some areas of southern Europe, even if low, in order to
avoid the life-threatening manifestations of strongyloidiasis favoured by pathological or therapeutic
immunosuppression.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Strongyloidiasis is a neglected but widespread parasitic disease
caused by infection with the nematode Strongyloides stercoralis and to
a lesser extent by the zoonotic species Strongyloides fuelleborni.1 It is
common in tropical and subtropical areas, where heat and humidity
favour the growth of geohelminths in general. However, endemic-
sporadic transmission can also be observed in some temperate
countries, such as the USA,2 Japan,3 Italy,4,5 France,6 and Spain.7–10
S. stercoralis is unique among geohelminths in its ability to
develop two distinct reproductive cycles: one asexual cycle inside
the human host allowing autoinfection and the other involving
sexual reproduction into the soil. Due to autoinfection, one can
remain infected for decades without further environmental
exposure;1 this raises the issue of dating the exposure in areas
where there is a low risk of transmission, such as the southern
European countries. For this reason, data supporting recent
infections in Italy,4 Spain,9,10 and France,6 although scarce, are
of particular interest.
The incubation period is about 1 month and acute strongyloidia-
sis is generally unnoticed. Chronic infection is often asymptomatic,* Corresponding author.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).or can be accompanied by mild gastrointestinal (dyspepsia, nausea,
vomiting, diarrhoea), respiratory (cough, wheezing), or cutaneous
manifestations (pruritus, urticaria, larva currens syndrome).7,11 If
documented, hypereosinophilia is frequently found in this situation.
In immunocompromised people, especially those receiving cortico-
steroids or immunosuppressants, severe and often fatal forms of the
disease, either hyperinfection syndrome or disseminated strongy-
loidiasis, can occur. Infection by human T lymphotropic virus type 1
(HTLV-1), by disrupting the anti-parasitic Th2-weighted immune
response and enhancing the Th1-oriented immune response, can
also promote these clinical forms.12
The parasitological diagnosis of strongyloidiasis remains
challenging due to the intermittent excretion of larvae in the
faeces. Routine coprology lacks sensitivity, and the reference
techniques, namely the Baermann method (using the hygro-
thermotropic characteristics of S. stercoralis larvae) and agar plate
culture, are time-consuming and cumbersome. ELISA serology is
more sensitive and could be helpful for screening purposes among
at-risk subjects.11
2. Case presentation
A 17-year-old French woman of Spanish origin (through her
parents), born and residing in the Bordeaux area of south western
France, was referred to our department by her general practitionerciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
A. Duvignaud et al. / International Journal of Infectious Diseases 42 (2016) 43–4444(GP) for chronic abdominal pain, involuntary weight loss, diarrhoea,
cough, pruritus, and a mild fever at 38.0 8C. Prior to her admission,
hypereosinophilia at 16.9  109/l (normal <0.7  109/l), which had
not been noticed before, was found on biological investigations. For
this reason, stool examinations by Telemann and Bailenger methods
(diphasic enrichment techniques, using acetic acid solution and
acetic acid/sodium acetate buffer, respectively, for the concentration
of helminth eggs and larvae) were prescribed by the GP and rare S.
stercoralis rhabditoid larvae were found.
On questioning, the patient acknowledged chronic intermittent
abdominal pain and discomfort, with a possible initial gastroen-
teritis-like episode following a recreational stay in western Spain,
near the Portuguese border (district El Payo, Castilla y Leon) in
which she had walked barefoot on a riverside before swimming,
about 8 years ago. Over time, the episodes of abdominal pain had
become increasingly frequent and severe and were accompanied
by diarrhoea. She had also experienced episodic urticaria for 1 year
and bronchial hyper-reactivity.
The patient had never travelled outside occidental Europe, but
had travelled to Spain on several occasions with her family.
Between 1995 and 2005, she had stayed each summer on the
Mediterranean coast in the district of Safor, near Valencia. She
went to western Spain near the Portuguese border in 2004 and
2005, where she reported walking barefoot on muddy banks before
swimming in rivers and in an antique Roman pool with thermal
waters (district El Payo, Castilla y Leon). Thereafter, she visited
coastal Galicia near La Corun˜a and Santiago de Compostella in
2006, during which time she had also walked barefoot before
swimming in rivers and brackish lakes.
The treatment she received consisted of oral ivermectin at a
dosage of 200 mg/kg, repeated twice, 1 week apart. This was well
tolerated and all the symptoms improved rapidly. Multiple stool
examinations with Baermann enrichment method performed
1 month after the second intake conﬁrmed the eradication of S.
stercoralis larvae. Moreover, her eosinophil count returned to
normal values within a few weeks. No serological testing could be
performed. More than 2 years after treatment, there has been no
clinical or biological evidence of relapse.
3. Discussion
Strongyloidiasis is generally considered by physicians to be rare in
temperate countries. However, autochthonous cases are still
reported in some developed countries, especially in southern Europe,
among people who have never travelled to tropical or subtropical
areas. Of note, almost all of these cases concern elderly people with
chronic infections acquired a long time ago. Consequently, the
possibility for ongoing transmission remains a matter of debate.
In Europe, Spain is the country with the highest number of
reported cases. Some areas have been clearly identiﬁed to have
concentrated cases of strongyloidiasis,7–9 especially in farm work-
ers,7,9 who seem to have an increased risk of infection by S.
stercoralis. A study conducted in the district of Safor (Valencian
community in Spain), found a prevalence as high as 12.4% in this
group of people.8Most cases were found among males aged 50 years
and older,7–9 raising the issue of past contamination followed by
autoinfection. An explanation for this could be that the types of crop
grown in this area have changed over the last decades. The culture of
rice, which was expanded in the 1970s, has become less common,and has been replaced with other crops, such as citrus trees.
Moreover, the level of sanitation improved substantially over the
same period. As a consequence, the risk of infection has decreased.
However, the present case patient supports the hypothesis of
persisting sporadic autochthonous transmission, since she was
only 17 years old at diagnosis and had not travelled outside of
occidental Europe and more precisely outside France and Spain.
From her history, the three most likely places of contamination are
the district of El Payo, near the Portuguese border (south of Castilla
y Leon), where no cases of strongyloidiasis have been reported to
the best of our knowledge, the southern part of coastal Galicia,
where an autochthonous case of strongyloidiasis in a young patient
has already been reported,10 and the district of Safor, near Valencia
on the Mediterranean coast, where she stayed every summer for
10 years and where the majority of Spanish locally acquired cases
of strongyloidiasis have been reported, mostly among elderly
farmers.7–9 Regardless, this case raises the hypothesis of ongoing
autochthonous transmission in some areas of Spain and more
generally in southern Europe.
In conclusion, although it concerns mainly tropical and
subtropical areas, similar to other geohelminth infections, one
should consider autochthonous strongyloidiasis when facing unex-
plained hypereosinophilia with or without compatible symptoms in
subjects who have never travelled outside Europe, especially those
who have frequented the southern areas of the continent. This is
even more essential when treatment with corticosteroids or
immunosuppressants is to be started, in order to avoid the most
severe and potentially life-threatening forms of the disease.
Conﬂict of interest: The authors declare they have no conﬂict of
interest in relation to this article.
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